Geron Corp (NASDAQ:GERN)
During the Trading Day
| 1.12 |  0.00 / 0.00% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 1.12 | 0.00 / 0.00% |
Volume: 5.7K |
Latest GERN News | Press Releases
No recent news for Geron Corp.
Today’s Trading
| Previous close | 1.12 |
| Today’s open | 1.10 |
| Day’s range | 1.09 - 1.13 |
| Volume | 392,723 |
| Average volume (3 months) | 750,448 |
| Market cap | $146.1M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +30.77% |
| Earnings growth (this year) | +44.07% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +11.12% |
| P/E ratio | NM |
| Price/Sales | 66.07 |
| Price/Book | 1.70 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Medytox Solutions In... | 0.00 | 0.00% |
| INOInovio Pharmaceutica... | +0.02 | +2.90% |
| BDSIBioDelivery Sciences... | -0.03 | -0.67% |
| TROVTrovagene Inc | -0.06 | -0.86% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $2.7M |
| Annual profit (last year) | -$68.9M |
| Net profit margin | -2,542.67% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director John A. Scarlett, MD |
Chief Financial Officer, Treasurer, CAO & SVP Olivia K. Bloom, CPA |
Corporate headquarters Menlo Park, California |
Forecasts
